Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChulaCov19 Vaccine in Healthy Adults
NCT04566276Phase 2Completed
- Sponsor
- Chulalongkorn University
- Start
- May 2021
- Primary completion
- Oct 2022
- Modality
- Vaccine mRNA, mRNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of ChulaCov19 in coronavirus disease 2019 (COVID-19), sponsored by Chulalongkorn University. Started May 2021; status: completed.
02
Drugs
ChulaCov19
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04566276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04566276.